Glaucoma News

SAN FRANCISCO — The current glaucoma treatment landscape features a growing patient population, new market segments and acceptance of novel treatments, according to a speaker here.

To celebrate the 40th anniversary of Healio/Ocular Surgery News, the Associate Medical Editors are sharing what they think are the most important ophthalmic innovations of the 1990s.

TearClear has initiated a phase 3 trial evaluating TC-002, a preservative-free latanoprost ophthalmic solution, in patients with glaucoma, according to a press release.

WAIKOLOA, Hawaii — With several good MIGS options, the choice often comes down to matching the procedure with the patient, according to a presentation at Hawaiian Eye 2022.

Hyperemia, a side effect of some glaucoma medications, may cause patients to pause their treatments, according to a survey conducted by Bausch + Lomb and the Glaucoma Research Foundation.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Michael Greenwood, MD, discusses the benefits of adding endoscopic cyclophotocoagulation to any minimally invasive glaucoma surgery.

The final 2021 issue of the Video Journal of Cataract, Refractive, and Glaucoma Surgery, which advances the knowledge and surgical training of ophthalmic surgeons through video-based education, is now online.

WAIKOLOA, Hawaii — Surgeons need to consider the risks and possible refractive outcomes before implanting a premium IOL in a patient with glaucoma, according to a presentation at Hawaiian Eye 2022.

WAIKOLOA, Hawaii — Ophthalmologists should consider co-management of other diseases when treating progressive glaucoma, according to a speaker here.

WAIKOLOA, Hawaii — Clinical research, personal experience, physician skill set, patient factors and goals all influence the decision to perform trabeculectomy or use a tube shunt, a speaker said here at Hawaiian Eye 2022.